Wiebe C et al. |
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development. |
2017 |
J. Am. Soc. Nephrol. |
pmid:28729289
|
Abongwa C et al. |
Successful treatment of tacrolimus-related pure red cell aplasia and autoimmune hemolytic anemia with rituximab in a pediatric cardiac transplant patient. |
2017 |
Pediatr Blood Cancer |
pmid:28598573
|
Wu Z et al. |
FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients. |
2017 |
Eur. J. Clin. Pharmacol. |
pmid:27747372
|
Harada S et al. |
Complete remission of angiolymphoid hyperplasia with eosinophilia using topical tacrolimus. |
2017 |
Eur J Dermatol |
pmid:28007668
|
Ferjani H et al. |
Beneficial effects of mycophenolate mofetil on cardiotoxicity induced by tacrolimus in wistar rats. |
2017 |
Exp. Biol. Med. (Maywood) |
pmid:26582055
|
Cui W et al. |
Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy. |
2017 |
Braz. J. Med. Biol. Res. |
pmid:28355356
|
Kim YK et al. |
New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients. |
2017 |
Drug Des Devel Ther |
pmid:29033547
|
Dutta D et al. |
Recruitment of calcineurin to the TCR positively regulates T cell activation. |
2017 |
Nat. Immunol. |
pmid:27941787
|
Gatault P et al. |
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study. |
2017 |
Am. J. Transplant. |
pmid:27862923
|
Gaynor JJ and Ciancio G |
The Importance of Using Serially Measured Tacrolimus Clearance Values, Especially During the Early Posttransplantation Period. |
2018 |
Transplantation |
pmid:29271869
|
Nakahara T et al. |
Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis. |
2018 |
Pediatr Allergy Immunol |
pmid:29205511
|
Nakamura K et al. |
Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model. |
2018 |
Transpl. Immunol. |
pmid:28988984
|
Sablik KA et al. |
Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection. |
2018 |
PLoS ONE |
pmid:29746495
|
Thishya K et al. |
Artificial neural network model for predicting the bioavailability of tacrolimus in patients with renal transplantation. |
2018 |
PLoS ONE |
pmid:29621269
|
Riva N et al. |
Survival Time to Biopsy-Proven Acute Rejection and Tacrolimus Adverse Drug Reactions in Pediatric Liver Transplantation. |
2018 |
Ther Drug Monit |
pmid:29621122
|
Goto T et al. |
Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan. |
2018 |
Int. J. Hematol. |
pmid:29027623
|
Liu J et al. |
Donor and recipient P450 gene polymorphisms influence individual pharmacological effects of tacrolimus in Chinese liver transplantation patients. |
2018 |
Int. Immunopharmacol. |
pmid:29454235
|
Choi CB et al. |
Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis. |
2018 |
Lupus |
pmid:29448881
|
Yoon CH et al. |
Topical Tacrolimus 0.03% for Maintenance Therapy in Steroid-Dependent, Recurrent Phlyctenular Keratoconjunctivitis. |
2018 |
Cornea |
pmid:29309358
|
Buchholz BM et al. |
Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients. |
2018 |
World J. Gastroenterol. |
pmid:30065563
|